A Popular Weight Loss Drug Is Getting a Price Cut
Eli Lilly will now sell cheaper vials of Zepbound, presenting a direct challenge to telehealth companies that offer compounded versions of the medication. By Dani Blum from NYT (New York Times) Well
Read more.